GoHealth (NASDAQ:GOCO – Get Free Report)‘s stock had its “market perform” rating reaffirmed by equities researchers at William Blair in a research report issued to clients and investors on Wednesday,Benzinga reports.
A number of other brokerages also recently commented on GOCO. Royal Bank Of Canada lowered their price objective on GoHealth from $18.00 to $12.00 and set a “sector perform” rating for the company in a research report on Thursday, August 28th. Noble Financial restated an “outperform” rating on shares of GoHealth in a report on Friday, August 8th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of GoHealth in a report on Wednesday, November 5th. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, GoHealth has an average rating of “Hold” and a consensus target price of $12.00.
View Our Latest Report on GoHealth
GoHealth Price Performance
GoHealth (NASDAQ:GOCO – Get Free Report) last announced its quarterly earnings data on Thursday, November 13th. The company reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.06) by $1.87. The business had revenue of $34.19 million for the quarter, compared to the consensus estimate of $102.36 million. GoHealth had a negative net margin of 26.95% and a positive return on equity of 8.00%. Equities analysts predict that GoHealth will post -5.5 earnings per share for the current year.
Institutional Trading of GoHealth
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Public Sector Pension Investment Board purchased a new stake in shares of GoHealth during the 3rd quarter valued at about $8,100,000. Redwood Capital Management LLC purchased a new stake in GoHealth during the 3rd quarter worth $4,455,000. 4D Advisors LLC acquired a new stake in shares of GoHealth during the first quarter valued at about $1,840,000. Focus Partners Wealth acquired a new position in shares of GoHealth in the third quarter worth about $270,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new position in GoHealth in the first quarter valued at about $212,000. Institutional investors and hedge funds own 24.21% of the company’s stock.
About GoHealth
GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.
Recommended Stories
- Five stocks we like better than GoHealth
- Find and Profitably Trade Stocks at 52-Week Lows
- Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum
- How to Buy Cheap Stocks Step by Step
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- How to Invest in the Best Canadian Stocks
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.
